Skip to main content

Table 1 Group Characteristics and Medications

From: Short term elevation in dietary protein intake does not worsen insulin resistance or lipids in older adults with metabolic syndrome: a randomized-controlled trial

Intervention

Recommended Protein Intake

Elevated Protein Intake

Pre

Post

Pre

Post

Age, yrs

64.5 ± 3.0

60.2 ± 2.8

Gender, M/F

3/3

2/4

Total body mass, kg

108.5 ± 10.6

108.5 ± 10.5

106.0 ± 6.8

105.3 ± 6.8

Lean body mass, kg

59.0 ± 7.4

57.3 ± 6.0

58.1 ± 4.6

56.4 ± 3.8

Body mass index, kg/m2

37.4 ± 2.6

37.4 ± 2.6

37.6 ± 1.4

37.3 ± 1.4

Body fat (%)

41.3 ± 7.5

 

41.2 ± 3.4

 

Total cholesterol, mg/dl

198.3 ± 43.6

 

188.7 ± 37.9

 

Triglyceride, mg/dl

185.3 ± 60.9

 

171.2 ± 41.5

 

HDL cholesterol, mg/dl

44.2 ± 10.1

 

41.5 ± 7.1

 

Glucose, mg/dl

102.5 ± 23.1

 

99.2 ± 14.3

 

Blood pressure, mm Hg

 Systolic blood pressure

143.0 ± 21.8

 

145.2 ± 17.2

 

 Diastolic blood pressure

85.0 ± 9.5

 

82.8 ± 5.4

 
 

Medications (# of subjects)

For hypertension

    

 Beta blocker

  

2

 

 ACE inhibitor

1

 

2

 

 Calcium channel blocker

1

 

1

 

 Diuretic

2

 

5

 

For lipid or type 2 diabetes

    

 Metformin

1

 

2

 

 Glipizide

1

   

 Statin

2

 

1

 
  1. Values are expressed as Mean ± SEM. M/F number of male/female subjects. There were no significance differences in any of variables of group characteristics before and after their respective dietary intervention between groups (for all; p > 0.10)